ClinConnect ClinConnect Logo
Search / Trial NCT01083992

Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)

Launched by ZIV HOSPITAL · Mar 9, 2010

Trial Information

Current as of June 04, 2025

Unknown status

Keywords

Nafld Galvus Vitamin D

ClinConnect Summary

Sedentary lifestyle and poor dietary choices are leading to a weight gain epidemic and increasing the risk for developing nonalcoholic fatty liver disease (NAFLD). The strong relationship between insulin resistance and NAFLD suggests that adding vitamin D to insulin sensitizing therapies such as Galvus (vitagliptin) might be beneficial in the prevention or improvement in NAFLD. Considering the close relationship between NAFLD and T2DM and lipid metabolism, we assume that adding vitamin D to Galvus may be effective for NAFLD by improving lipid metabolism and by improving T2DM. Methods: 60 pa...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18-65 years old
  • Men and women with NAFLD per US
  • Increased ALT level
  • Hepatomegaly
  • Liver biopsy within 2 years
  • Exclusion Criteria:
  • Other liver diseases (HBV, HCV)
  • Hepatocellular carcinoma
  • Decompensated liver disease
  • Use of steroids

About Ziv Hospital

Ziv Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in Israel, the hospital is equipped with state-of-the-art facilities and a multidisciplinary team of healthcare professionals committed to exploring new therapies and treatment modalities across various medical fields. By fostering collaboration between researchers, physicians, and patients, Ziv Hospital aims to contribute significantly to the scientific community and enhance the quality of care provided to its diverse patient population.

Locations

Safed, Israel, , Israel

Patients applied

0 patients applied

Trial Officials

Nimer Assy, MD

Principal Investigator

ZIV MEDICAL CENTER, SAFED ISRAEL

ASSY NIMER, MD

Principal Investigator

Ziv medical center safed, israel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials